News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

SpinalCyte, LLC Reports the Addition of Nicholas Theodore, M.D. to Clinical Advisory Board



10/22/2012 9:44:05 AM

HOUSTON--(BUSINESS WIRE)--SpinalCyte, LLC, a spinal technology company focused on autologous regrowth of the spinal disc nucleus using human dermal fibroblasts (HDFs), today announced the addition of Nicholas Theodore, M.D. to its Clinical Advisory Board. Dr. Theodore, Director of Neurosurgery Spine Program, Barrow Neurological Institute, is one of the top spine surgeons and researchers in the country.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES